Ranbaxy signs agreement with CD Pharma for 'Inersan' pills

New Delhi, Mar 18 (UNI) Pharmaceutical major Ranbaxy Laboratories Ltd today said it has signed an exclusive in-licensing agreement with CD Pharma to market Inersan tablets, used for the treatment of dental problems, in the country along with Nepal.

Inersan, first of its kind natural biological patented product to be introduced in the country, will be used to treat dental problems such as Periodontitis, Gingivitis and Halitosis, a statement said.

At present, there is no particular drug available for the treatment of these dental problems, which can affect a person's overall health.

UNI SG SBA SSC1338